HH
VRTX icon

Hilltop Holdings’s Vertex Pharmaceuticals VRTX Stock Holding History

Hilltop Holdings’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-671
Closed -$300K – 720
2026
Q1 		$300K Sell
671
-2,344
-78% -$1.09M 0.03% 516
2025
Q4 		$1.37M Sell
3,015
-1,919
-39% -$827K 0.08% 270
2025
Q3 		$1.93M Buy
4,934
+757
+18% +$316K 0.1% 219
2025
Q2 		$1.86M Buy
4,177
+542
+15% +$250K 0.12% 200
2025
Q1 		$1.76M Buy
3,635
+90
+3% +$41.9K 0.11% 198
2024
Q4 		$1.43M Buy
3,545
+402
+13% +$186K 0.09% 240
2024
Q3 		$1.46M Buy
3,143
+2,459
+360% +$1.18M 0.09% 234
2024
Q2 		$321K Hold
684
– – 0.04% 459
2024
Q1 		$286K Buy
684
+2
+0.3% +$845 0.03% 516
2023
Q4 		$277K Sell
682
-10
-1% -$3.69K 0.03% 485
2023
Q3 		$241K Sell
692
-11
-2% -$3.85K 0.03% 502
2023
Q2 		$247K Sell
703
-7
-1% -$2.36K 0.03% 481
2023
Q1 		$224K Sell
710
-2
-0.3% -$600 0.03% 476
2022
Q4 		$206K Hold
712
– – 0.03% 490
2022
Q3 		$206K Buy
+712
New +$205K 0.03% 468
2021
Q2 		– Sell
-1,509
Closed -$324K – 591
2021
Q1 		$324K Buy
+1,509
New +$331K 0.04% 386
2020
Q3 		– Sell
-757
Closed -$220K – 452
2020
Q2 		$220K Buy
+757
New +$205K 0.04% 351
2018
Q4 		– Sell
-1,534
Closed -$296K – 423
2018
Q3 		$296K Buy
+1,534
New +$273K 0.06% 321

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Hilltop Holdings's VRTX Position: Q2 2026 in Review

Hilltop Holdings sold out of Vertex Pharmaceuticals (VRTX) in Q2 2026, closing a stake of 671 shares — an estimated $300K sold.

Hilltop Holdings first reported a position in VRTX in Q3 2018 and held it in 18 quarters. The position peaked at $1.93M in Q3 2025. 1,758 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Hilltop Holdings reported no remaining Vertex Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Hilltop Holdings sold 671 Vertex Pharmaceuticals shares in Q2 2026, an estimated $300K.
  • Hilltop Holdings first reported a position in Vertex Pharmaceuticals in Q3 2018 and held it in 18 quarters.
  • Hilltop Holdings's Vertex Pharmaceuticals position peaked at $1.93M in Q3 2025.
  • 1,758 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Hilltop Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.